NCT06804785View on ClinicalTrials.gov

Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2028

Conditions
Prostate Cancer
Trial Locations (1)

20892

RECRUITING

National Institutes of Health, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT06804785 - Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS) | Biotech Hunter | Biotech Hunter